Stocks
Cara Therapeutics (CARA) EV/EBITDA US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | |||
| EV/EBITDA | ? | 96.8 | -5.10 | -4.94 | 0.14 | 0.15 | -0.33 | |
| Changes by years, y/y, % | -2 115% | -105% | -3% | -103% | +3% | |||
Cara Therapeutics. EV/EBITDA
Cara Therapeutics. EV/EBITDA, changes, %
Cara Therapeutics (CARA) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| EV/EBITDA | ? | -0.51 | -0.17 | 0.14 | 0.15 | -0.21 | -0.33 | |
| Changes by years, y/y, % | -90% | -96% | -103% | -103% | -88% | |||
| Changes by quarters, q/q, % | -70% | -68% | -185% | +2% | -245% | |||
